Over Ten-Year Kidney Graft Survival Determinants

Table 1

Recipient, donor, and kidney transplant characteristics of the enrolled population (𝑛=892).

Characteristics	Patients
Recipient
Age (years), median [IQR]	37.0 [27.6–47.1]
Male gender, n (%)	530 (59.4%)
Time on dialysis (years), median [IQR]	2.6 [1.4–5.0]
Body mass index (kg/m^2), median [IQR]	22.4 [20.3–24.2]
Dialysis technique
Hemodialysis, n (%)	864 (96.3%)
Peritoneal dialysis, n (%)	16 (1.8%)
Prior kidney transplant, n (%)	73 (8.1%)
Positive CMV IgG, n (%)	613 (68.3%)
Prior blood transfusion (≥3 units), n (%)	350 (39.1%)
Hepatitis B/C+, n (%)	230 (25.6%)
Donor
Age (years), median [IQR]	25.0 [18.0–39.0]
Male gender, n (%)	636 (70.9%)
Serum creatinine (mg/dL), median [IQR]	1.0 [0.8–1.2]
Cadaveric donor, n (%)	888 (99.0%)
Transplant
0 mismatches HLA-B, n (%)	181 (20.2%)
1 mismatches HLA-B, n (%)	249 (27.8%)
2 mismatches HLA-B, n (%)	428 (47.7%)
PRA ≥ 30%, n (%)	34 (3.8%)
ATG induction protocol, n (%)	411 (45.8%)
Delayed graft function, n (%)	294 (32.8%)
Acute rejection, n (%)	283 (31.5%)
Serum creatinine at 12 months (mg/dL),  median [IQR]	1.40 [1.20–1.70]

IQR: interquartile range; IgG CMV: immunoglobulin cytomegalovirus; HLA: human leucocyte antigen; PRA: panel reactive antibody; ATG: antithymoglobulin.